Study revisits 1st clinical trial to treat MS decades later
Study revisits 1st clinical trial to treat MS decades later
Tracking down nearly all 372 multiple sclerosis patients involved in a pivotal clinical trial of a drug decades ago has allowed a group of researchers from several institutions, led by professors at the University of California, San Francisco (UCSF) and the University of Chicago, to a surprising discovery.
The clinical trial, conducted in the late 1980s, involved the biotech drug interferon beta-1b – an injectable protein that in 1993 became the first pharmaceutical approved by the U.S. Food and Drug Administration for treating multiple sclerosis.
Now, more than two decades later, the researchers are reporting that the people who received interferon in the trial, as opposed to a placebo, were only about half as likely to have died in the decades since....
Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1766
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 12784 Views
-
Last post by NHE
-
- 1 Replies
- 1936 Views
-
Last post by raceya
-
- 0 Replies
- 1104 Views
-
Last post by frodo
-
- 0 Replies
- 1504 Views
-
Last post by DIM
-
- 0 Replies
- 2472 Views
-
Last post by NHE
-
- 0 Replies
- 1957 Views
-
Last post by DIM
-
- 0 Replies
- 2176 Views
-
Last post by DIM
-
- 0 Replies
- 1636 Views
-
Last post by frodo
-
- 0 Replies
- 1970 Views
-
Last post by Tif